# OnCo record idea-tnbc-uk-trial-access-and-germline-testing-audit (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-tnbc-uk-trial-access-and-germline-testing-audit/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-tnbc-uk-trial-access-and-germline-testing-audit" ;
  schema:name "A UK audit of trial access and germline testing uptake in triple-negative breast cancer"@en ;
  schema:description "Every triple-negative patient under 60 in the UK should be offered a BRCA test at diagnosis because the result now changes treatment, and many should be offered a trial, but no one publishes how many are. A national audit through existing cancer registration and genomic laboratory data would show the gap by region before anyone tries to close it."@en ;
  schema:url <https://onco.cc/ideas/idea-tnbc-uk-trial-access-and-germline-testing-audit/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://europepmc.org/article/MED/42636977>, <https://europepmc.org/article/MED/18779615> ;
  onco:tag "tnbc-evidence" ;
  onco:related <https://onco.cc/ideas/idea-tnbc-disparities-in-access-and-outcomes/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:institutions <https://onco.cc/institutions/nice/>, <https://onco.cc/institutions/cruk/> ;
  onco:terms <https://onco.cc/technologies/germline-testing/> ;
  onco:trials <https://onco.cc/trials/olympia/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-hereditary-risk/>, <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-data-silos/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-olympia-6-year-update-ann-oncol-2026/>, <https://onco.cc/key-papers/paper-atchley-brca-status-triple-negative-jco-2008/>, <https://onco.cc/key-papers/paper-asco-hereditary-breast-cancer-guideline-jco-2020/>, <https://onco.cc/key-papers/paper-copson-posh-ethnicity-young-breast-cancer-uk-bjc-2014/> .
